Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRUX
Columbia Core Bond ETF
CRUX
|
+$707M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$684M |
| 3 |
Micron Technology
MU
|
+$655M |
| 4 |
EOG Resources
EOG
|
+$556M |
| 5 |
Broadcom
AVGO
|
+$511M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.1B |
| 2 |
Visa
V
|
+$870M |
| 3 |
Bloom Energy
BE
|
+$845M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$809M |
| 5 |
Microsoft
MSFT
|
+$723M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.89% |
| 2 | Financials | 10.23% |
| 3 | Industrials | 8.46% |
| 4 | Healthcare | 7.99% |
| 5 | Consumer Discretionary | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Schwab Fundamental International Small Company Index ETF
FNDC
$3.01B
| $904K | ﹤0.01% |
19,508
+699
| +4% | +$33.1K |
|
3302
Summit Therapeutics
SMMT
$10.9B
| $904K | ﹤0.01% |
47,667
-6,345
| -12% | -$103K |
|
3303
Phreesia
PHR
$632M
| $903K | ﹤0.01% |
107,747
-738,714
| -87% | -$9.77M |
|
3304
Upland Software
UPLD
$12M
| $903K | ﹤0.01% |
135,564
+1,545
| +1% | +$16.2K |
|
3305
CareDx
CDNA
$1.92B
| $901K | ﹤0.01% |
51,907
-642
| -1% | -$12.2K |
|
3306
Nice
NICE
$5.29B
| $901K | ﹤0.01% |
8,168
-965
| -11% | -$110K |
|
3307
Jakks Pacific
JAKK
$280M
| $899K | ﹤0.01% |
45,130
-6,515
| -13% | -$126K |
|
|
GDEN
3308
DELISTED
Golden Entertainment
GDEN
| $897K | ﹤0.01% |
33,618
-863
| -3% | -$23.9K |
|
3309
Coastal Financial
CCB
$1.1B
| $894K | ﹤0.01% |
11,748
-640
| -5% | -$57.8K |
|
3310
Citi Trends
CTRN
$524M
| $892K | ﹤0.01% |
20,598
-4,263
| -17% | -$194K |
|
|
KE
3311
Kimball Electronics
KE
$598M
| $891K | ﹤0.01% |
37,611
-13,394
| -26% | -$354K |
|
3312
Procept Biorobotics
PRCT
$950M
| $890K | ﹤0.01% |
35,599
-3,414
| -9% | -$96.2K |
|
3313
Washington Trust Bancorp
WASH
$732M
| $890K | ﹤0.01% |
26,600
-11,280
| -30% | -$372K |
|
3314
Rimini Street
RMNI
$408M
| $888K | ﹤0.01% |
270,626
+13,456
| +5% | +$46.7K |
|
3315
Entrada Therapeutics
TRDA
$227M
| $887K | ﹤0.01% |
70,280
-14,613
| -17% | -$167K |
|
3316
Ultragenyx Pharmaceutical
RARE
$2.65B
| $886K | ﹤0.01% |
42,295
-234,632
| -85% | -$5.28M |
|
3317
NB Bancorp
NBBK
$983M
| $884K | ﹤0.01% |
41,959
-36,641
| -47% | -$770K |
|
3318
Nuveen Real Asset Income & Growth Fund
JRI
$358M
| $880K | ﹤0.01% |
70,453
+18,977
| +37% | +$247K |
|
3319
Copel
ELPC
$8.49B
| $878K | ﹤0.01% |
71,885
+2,397
| +3% | +$25.5K |
|
3320
SunCoke Energy
SXC
$757M
| $876K | ﹤0.01% |
134,538
-290,668
| -68% | -$2.06M |
|
|
RA
3321
Brookfield Real Assets Income Fund
RA
$703M
| $873K | ﹤0.01% |
67,905
+11,337
| +20% | +$148K |
|
3322
Innovative Solutions & Support
ISSC
$342M
| $873K | ﹤0.01% |
42,510
+25,529
| +150% | +$592K |
|
3323
Capital Group Global Growth Equity ETF
CGGO
$11.2B
| $871K | ﹤0.01% |
26,087
+5,628
| +28% | +$200K |
|
3324
Prothena Corp
PRTA
$458M
| $867K | ﹤0.01% |
89,212
-16,229
| -15% | -$149K |
|
|
DFUS
3325
Dimensional US Equity ETF
DFUS
$20.7B
| $867K | ﹤0.01% |
12,224
-2,115
| -15% | -$157K |
|
Similar funds
Ameriprise's Q1 2026 Portfolio in Review
As of Q1 2026, Ameriprise held 4,261 positions worth $432B, down 2.4% from $443B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ameriprise's Q1 2026 filing shows 190 new, 1,715 increased, 2,050 reduced and 216 closed positions. Its largest new stake was Columbia Core Bond ETF: 23,603,545 shares worth $709M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.1B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
- Ameriprise's largest Q1 2026 buy was Columbia Core Bond ETF: 23,603,545 shares worth $709M.
- Ameriprise added most to Berkshire Hathaway Class B in Q1 2026, an estimated $684M increase.
- Ameriprise's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.1B.
- Ameriprise fully exited Exact Sciences in Q1 2026, selling an estimated $174M.
- Ameriprise's ten largest holdings make up 19% of its $432B portfolio in Q1 2026.
- Ameriprise opened 190 new positions and closed 216 in Q1 2026.
- Ameriprise's portfolio value fell 2.4% quarter-over-quarter to $432B.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.